SCHEMBL4454563

SCHEMBL4454563

N=C1COCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2923012 0.97
Acetic Acid SCHEMBL4452287 0.85 GAA (0.33)
Hydrochloric Acid SCHEMBL8467105 0.82
SCHEMBL7678958 0.76
Hydrochloric Acid SCHEMBL7683971 0.74
SCHEMBL14045629 0.71
SCHEMBL90056 0.67
SCHEMBL3831112 0.67
SCHEMBL77344 0.67
Hydrochloric Acid SCHEMBL29493442 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312203-A1 Bicyclic 6-Alkylidene-Penems as Beta-Lactamase Inhibitors WYETH (US) 2008-12-18 US claimed
US-20240336611-A1 ANALOGS FOR THE TREATMENT OF DISEASE INSILICO MEDICINE IP LIMITED (HK) 2024-10-10 US disclosed
EP-4298094-A1 ANALOGS FOR THE TREATMENT OF DISEASE Insilico Medicine IP Limited (HK) 2024-01-03 EP disclosed
CN-117222642-A Analogues for the treatment of disease 英矽智能科技知识产权有限公司 2023-12-12 CN disclosed
US-11834449-B2 TYK2 inhibitors and uses thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-12-05 US disclosed
CN-113423262-B Flowable concentrate composition for agricultural seeds 陶氏环球技术有限责任公司 2023-09-26 CN disclosed
CN-116726178-A Use of sGC stimulators in the treatment of non-alcoholic steatohepatitis (NASH) 赛克里翁治疗有限公司 2023-09-12 CN disclosed
WO-2022179529-A1 ANALOGS FOR THE TREATMENT OF DISEASE INSILICO MEDICINE IP LIMITED (CN) 2022-09-01 WO disclosed
US-11053241-B2 TYK2 inhibitors and uses thereof NIMBUS LAKSHMI, INC. (US) 2021-07-06 US disclosed
US-20200172540-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2020-06-04 US disclosed
WO-2020112937-A1 TYK2 INHIBITORS AND USES THEREOF NIMBUS LAKSHMI, INC. (US) 2020-06-04 WO disclosed
US-20090018332-A1 Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors WYETH (US) 2009-01-15 US disclosed
US-20090018332-A1 Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors WYETH (US) 2009-01-15 US disclosed
US-20090018332-A1 Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors WYETH (US) 2009-01-15 US disclosed
WO-2009006243-A2 PROCESSES FOR PREPARING BICYCLIC OXAZINE CARBOXALDEHYDE AND BETA-LACTAMASE INHIBITORS WYETH (US) 2009-01-08 WO disclosed
WO-2009006243-A2 PROCESSES FOR PREPARING BICYCLIC OXAZINE CARBOXALDEHYDE AND BETA-LACTAMASE INHIBITORS WYETH (US) 2009-01-08 WO disclosed